-
Adding low levels of fluoride to water has long been considered one of the greatest health achievements. Now comes an analysis of previously published research that concludes a link with intelligence.
-
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
-
President Joe Biden is under pressure to undergo cognitive testing even though his physician says he passes an annual neurologic exam. But what can the brief screening tool actually tell about a person’s brain health?
-
Music is a powerful way to help the brain rewire, says one expert. That's the basis of Strokestra a new program being developed with guidance from England's Royal Philharmonic.
-
A neurologist and neuropathologist address the prevalence, risk factors, early detection signs and preventive measures related to brain diseases.
-
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced.
-
A gene called APOE4 has long been considered a key risk factor. But new research says if people inherit two copies of that gene it's not just a risk — it appears to be the underlying cause.
-
Because music helps people with Alzheimer's and other forms of dementia bring out memories, some Jews in South Florida find Yiddish songs effective.
-
Epilepsy services are set to see their first stable source of funding from the state. The money is included in the Legislature’s budget for the upcoming fiscal year.
-
The treatment involves implanting electrodes in the brain that are attached to a device placed under the skin in the chest. Recent research is promising, and doctors believe federal approval may come soon.